Search Results - "Ho, Jenny M"
-
1
Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review
Published in Current oncology (Toronto) (29-03-2024)“…Myelodysplastic neoplasms (MDS) with ring sideroblasts (RS) are diagnosed via bone marrow aspiration in the presence of either (i) ≥15% RS or (ii) 5-14% RS and…”
Get full text
Journal Article -
2
CD200 expression marks leukemia stem cells in human AML
Published in Blood advances (10-11-2020)“…The leukemia stem cell (LSC) populations of acute myeloid leukemia (AML) exhibit phenotypic, genetic, and functional heterogeneity that contribute to therapy…”
Get full text
Journal Article -
3
Antidepressant efficacy of low-frequency repetitive transcranial magnetic stimulation in antidepressant-nonresponding bipolar depression: a single-blind randomized sham-controlled trial
Published in International Journal of Bipolar Disorders (08-12-2021)“…Background To examine the antidepressant efficacy and response predictors of R-DLPFC-LF rTMS for antidepressant-nonresponding BD. Methods We conducted a…”
Get full text
Journal Article -
4
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study
Published in Leukemia (01-03-2024)“…Myeloproliferative neoplasms (MPNs) are a group of chronic hematologic malignancies that lead to morbidity and early mortality due to thrombotic complications…”
Get full text
Journal Article -
5
A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) Study
Published in Journal of general internal medicine : JGIM (01-06-2023)“…Background Erythrocytosis, most often measured as an increase in hemoglobin and/or hematocrit, is a common reason for referral to internal medicine and…”
Get full text
Journal Article -
6
CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo
Published in Infection and immunity (01-07-2016)“…CD47 engagement by the macrophage signal regulatory protein alpha (SIRPα) inhibits phagocytic activity and protects red blood cells (RBCs) from…”
Get full text
Journal Article -
7
Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts
Published in The Journal of experimental medicine (24-09-2012)“…Although tumor surveillance by T and B lymphocytes is well studied, the role of innate immune cells, in particular macrophages, is less clear. Moreover, the…”
Get full text
Journal Article -
8
Emerging therapies for acute myeloid leukemia: translating biology into the clinic
Published in JCI insight (21-09-2017)“…Acute myeloid leukemia (AML) is an aggressive hematological malignancy with a poor outcome; overall survival is approximately 35% at two years and some…”
Get full text
Journal Article -
9
TEL-JAK2 constitutively activates the extracellular signal–regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways
Published in Blood (15-08-2002)“…The ets transcription factor, TEL, undergoes chromosomal rearrangements with the tyrosine kinase JAK2. TEL-JAK2 is constitutively active, confers cell line…”
Get full text
Journal Article -
10
Targeting SIRPα in cancer
Published in Oncoimmunology (01-02-2013)“…Strategies to harness the patient's immune system to fight cancer have mainly involved adoptive T-cell transfer. We and others have recently highlighted an…”
Get full text
Journal Article -
11
Rivaroxaban for Improvement in Thromboembolism Outcomes in Patients with Multiple Myeloma on Lenalidomide-Based Therapy: The Rithmm Feasibility Pilot Trial
Published in Blood (23-11-2021)“…Introduction:The association between thrombosis (TE) and cancer has been well established. The risk for thrombosis in Multiple Myeloma (MM) is further…”
Get full text
Journal Article -
12
Clinical Features and Mutational Landscape of Patients Referred for Suspected Essential Thrombocytosis: A Descriptive Study Using a 'Real-World’ Database
Published in Blood (15-11-2022)Get full text
Journal Article -
13
Stem Cell-Derived Gene Expression Scores Predict Survival and Leukemic Transformation in Myelofibrosis
Published in Blood (15-11-2022)Get full text
Journal Article -
14
Myelodysplastic Neoplasms with Ring Sideroblasts or ISF3B1/I Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review
Published in Current oncology (Toronto) (01-04-2024)“…Myelodysplastic neoplasms (MDS) with ring sideroblasts (RS) are diagnosed via bone marrow aspiration in the presence of either (i) ≥15% RS or (ii) 5–14% RS and…”
Get full text
Journal Article -
15
Myelofibrosis Is Initiated and Sustained By Rare Multipotent Stem Cells
Published in Blood (29-11-2018)“…Background: Myelofibrosis (MF) is a chronic myeloproliferative neoplasm (MPN) characterized by marked bone marrow fibrosis, extramedullary hematopoiesis and…”
Get full text
Journal Article -
16
HSCs Fated to Progress to Blast Phase Can be Detected in Myelofibrosis Patients Several Years Prior to Leukemic Transformation
Published in Blood (13-11-2019)“…In myeloproliferative neoplasms (MPN), somatic mutations in genes recurrently mutated in myeloid leukemia, apart from known MPN driver mutations (JAK2, MPL,…”
Get full text
Journal Article -
17
AML-Fated Clones Arise in Stem and Progenitor Cells in Myelofibrosis Patients Several Years Prior to AML Diagnosis
Published in Blood (29-11-2018)“…In myeloproliferative neoplasms (MPN), somatic mutations in recurrently mutated myeloid leukemia genes, apart from MPN driver genes, are common and can…”
Get full text
Journal Article -
18
Isolation of CD34− and CD34+ Leukemia Stem Cells from Acute Myeloid Leukemia Blasts Using CD200
Published in Blood (29-11-2018)“…Therapy resistance and relapse in acute myeloid leukemia (AML) are driven by leukemia stem cells (LSCs). Recent evidence highlighting functional and genetic…”
Get full text
Journal Article -
19
CD200 Is a Marker of LSC Activity in Acute Myeloid Leukemia
Published in Blood (02-12-2016)“…Acute myeloid leukemia (AML) is a hierarchical disease in which the bulk blast population is sustained by a minority population of leukemia stem cells (LSC)…”
Get full text
Journal Article -
20
Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing JAK1/2 Inhibitor Therapy
Published in Blood (02-12-2016)“…Introduction: The advent of next generation sequencing (NGS) has brought intense interest to the complex genetic landscape of myeloproliferative neoplasms…”
Get full text
Journal Article